The Role of Face Protection for Respiratory Viral Infections: A Historical Perspective. 2020

James D Cherry
Department of Pediatrics, David Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California, USA.

UI MeSH Term Description Entries
D008297 Male Males
D008397 Masks Devices that cover the nose and mouth to maintain aseptic conditions often for the prevention of the spread of infections (e.g. COVID19) or to administer inhaled anesthetics or other gases. Mask
D011024 Pneumonia, Viral Inflammation of the lung parenchyma that is caused by a viral infection. Pneumonias, Viral,Viral Pneumonia,Viral Pneumonias
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D005135 Eye Protective Devices Personal devices for protection of the eyes from impact, flying objects, glare, liquids, or injurious radiation. Goggles,Safety Glasses,Safety Lenses,Sun Glasses, Nonprescription,Device, Eye Protective,Devices, Eye Protective,Eye Protective Device,Glasses, Nonprescription Sun,Glasses, Safety,Lenses, Safety,Nonprescription Sun Glasses,Protective Device, Eye,Protective Devices, Eye
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000336 Aerosols Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents. Aerosol
D017758 Infectious Disease Transmission, Patient-to-Professional The transmission of infectious disease or pathogens from patients to health professionals or health care workers. It includes transmission via direct or indirect exposure to bacterial, fungal, parasitic, or viral agents. Disease Transmission, Patient-to-Professional,Transmission, Patient-to-Professional,Disease Transmission, Patient-Professional,Infection Transmission, Patient-Professional,Pathogen Transmission, Patient-Professional,Patient-to-Professional Disease Transmission,Patient-to-Professional Transmission,Transmission, Patient-Professional,Disease Transmission, Patient Professional,Disease Transmission, Patient to Professional,Infection Transmission, Patient Professional,Infectious Disease Transmission, Patient to Professional,Pathogen Transmission, Patient Professional,Patient to Professional Disease Transmission,Patient to Professional Transmission,Patient-Professional Disease Transmission,Patient-Professional Infection Transmission,Patient-Professional Infection Transmissions,Patient-Professional Pathogen Transmission,Patient-Professional Transmission,Transmission, Patient Professional,Transmission, Patient to Professional,Transmission, Patient-Professional Infection,Transmission, Patient-Professional Pathogen

Related Publications

James D Cherry
September 2022, Biomedical engineering online,
James D Cherry
March 2009, Infectious disease clinics of North America,
James D Cherry
June 1972, Canadian Medical Association journal,
James D Cherry
January 2014, Clinics in dermatology,
James D Cherry
November 2018, Infection control and hospital epidemiology,
James D Cherry
October 1962, American journal of diseases of children (1960),
Copied contents to your clipboard!